Factors determining normal adult height in girls with gonadotropin- dependent precocious puberty treated with depot gonadotropin-releasing hormone analogs

Journal of Clinical Endocrinology and Metabolism

Volumn 93, Issue 7, 2008, Pages 2662-2669

  Brito, Vinicius Nahime ^a   Latronico, Ana Claudia ^a   Cukier, Priscilla ^a   Teles, Milena Gurgel ^a   Silveira, Letícia F G ^a   Arnhold, Ivo Jorge Prado ^a   Mendonca, Berenice Bilharinho ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

GONADOTROPIN; GOSERELIN; LEUPRORELIN; TRIPTORELIN;

ADOLESCENT; AGE; ARTICLE; BODY HEIGHT; BONE AGE; CHILD; CLINICAL FEATURE; DRUG DOSE INCREASE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIPLE REGRESSION; MULTIVARIATE ANALYSIS; PRECOCIOUS PUBERTY; PRIORITY JOURNAL; PUBERTY; SCORING SYSTEM; UNIVARIATE ANALYSIS;

EID: 47549091769     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2007-2183     Document Type: Article

References (29)

1. Partsch CJ, Heger S, Sippell WG 2002 Management and outcome of central precocious puberty. Clin Endocrinol (Oxf) 56:129-148
2. Carel JC, Roger M, Ispas S, Tondu F, Lahlou N, Blumberg J, Chaussain JL 1999 Final height after long-term treatment with triptorelin slow release for central precocious puberty: importance of statural growth after interruption of treatment. J Clin Endocrinol Metab 84:1973-1978
3. Carel JC, Lahlou N, Roger M, Chaussain JL 2004 Precocious puberty and statural growth. Hum Reprod Update 10:135-147
4. Oostdijk W, Rikken B, Schreuder S, Otten B, Odink R, Rouwé C, Jansen M, Gerver WJ, Waelkens J, Drop S 1996 Final height in central precocious puberty after long term treatment with a slow release GnRH agonist. Arch Dis Child 75:292-297
5. Klein KO, Barnes KM, Jones JV, Feuillan PP, Cutler GBJ 2001 Increased final height in precocious puberty after long-term treatment with LHRH agonists: the National Institutes of Health experience. J Clin Endocrinol Metab 86:4711-4716
6. Arrigo T, Cisternino M, Galluzzi F, Bertelloni S, Pasquino AM, Antoniazzi F, Borrelli P, Crisafulli G, Wasniewska M, De Luca F 1999 Analysis of the factors affecting auxological response to GnRH agonist treatment and final height outcome in girls with idiopathic central precocious puberty. Eur J Endocrinol 141:140-144
7. Lazar L, Padoa A, Philip M 2007 Growth pattern and final height after cessation of gonadotropin-suppressive therapy in girls with central sexual precocity. J Clin Endocrinol Metab 92:3483-3489
8. Bayley N, Pinneau S 1952 Tables for predicting adult height from skeletal age. J Pediatr 14:432-441
9. Kauli R, Galatzer A, Kornreich L, Lazar L, Pertzelan A, Laron Z 1997 Final height of girls with central precocious puberty, untreated versus treated with cyproterone acetate or GnRH analogue. A comparative study with re-evaluation of predictions by the Bayley-Pinneau method. Horm Res 47:54-61
10. Antoniazzi F, Cisternino M, Nizzoli G, Bozzola M, Corrias A, De Luca F, De Sanctis C, Rigon F, Zamboni G, Bernasconi S 1994 Final height in girls with central precocious puberty: comparison of two different luteinizing hormone-releasing hormone agonist treatments. Acta Paediatr 83:1052-1056
11. Bar A, Linder B, Sobel EH, Saenger P and DiMartino-Nardi J 1995 Bayley-Pinneau method of height prediction in girls with central precocious puberty: correlation with adult height. J Pediatr 126:955-958
12. Heger S, Sippell WG, Partsch CJ 2005 Gonadotropin-releasing hormone analogue treatment for precocious puberty. Twenty years of experience. Endocr Dev 8:94-125
13. Marshall WA, Tanner JM 1969 Variations in pattern of pubertal changes in girls. Arch Dis Child 44:291-303
14. Marshall WA, Tanner JM 1970 Variations in the pattern of pubertal changes in boys. Arch Dis Child 45:13-23
15. Tanner JM, Whitehouse RH 1976 Clinical longitudinal standards for height, weight, height velocity, and weight velocity, and stages of puberty. Arch Dis Child 51:170-179
16. Kuczmarski RJ, Ogden CL, Grummer-Strawn LM, Flegal KM, Guo SS, Wei R 2000 CDC growth charts: United States. Adv Data 314:1-27
17. Lee PA 1994 Laboratory monitoring of children with precocious puberty. Arch Pediatr Adolesc Med 148:369-376
18. Brito VN, Batista MC, Borges MF, Latronico AC, Kohek MB, Thirone AC, Jorge BH, Arnhold IJ, Mendonca BB 1999 Diagnostic value of fluorometric assays in the evaluation of precocious puberty. J Clin Endocrinol Metab 84:3539-3544
19. Greulich WW, Pyle SI 1959 Radiographic atlas of skeletal development of the hand and wrist. Stanford, CA: Stanford University Press
20. Tanner JM, Goldstein H, Whitehouse RH 1970 Standards for children's height at ages 2-9 years allowing for height of parents. Arch Dis Child 45:755-762
21. Brito VN, Latronico AC, Arnhold IJ, Mendonça BB 2004 A single luteinizing hormone determination 2 hours after depot leuprolide is useful for therapy monitoring of gonadotropin-dependent precocious puberty in girls. J Clin Endocrinol Metab 89:4338-4342
22. Cassio A, Cacciari E, Balsamo A, Bal M, Tassinari D 1999 Randomized trial of LHRH analogue treatment on final height in girls with onset of puberty aged 7.5-8.5 years. Arch Dis Child 81:329-332
23. Mul D, Oostdijk W, Otten BJ, Rouwe C, Jansen M, Delemarre-van de Waal HA, Waelkens JJ, Drop SL 2000 Final height after gonadotrophin releasing hormone agonist treatment for central precocious puberty: the Dutch experience. J Pediatr Endocrinol Metab 13(Suppl 1):765-772
24. Heger S, Partsch CJ, Sippell WG 1999 Long-term outcome after depot gonadotropin-releasing hormone agonist treatment of central precocious puberty: final height, body proportions, body composition, bone mineral density, and reproductive function. J Clin Endocrinol Metab [Erratum (2000) 85:657] 84:4583-4590
25. Palmert MR, Mansfield J, Crowley Jr WF, Crigler JF, Crawford JD, Boepple PA 1999 Is obesity an outcome of gonadotropin-releasing hormone agonist administration? Analysis of growth and body composition in 110 patients with central precocious puberty. J Clin Endocrinol Metab 84:4480-4488
26. Badaru A, Wilson DM, Bachrach LK, Fechner P, Gandrud LM, Durham E, Wintergerst K, Chi C, Klein KO, Neely EK 2006 Sequential comparisons of one-month and three-month depot leuprolide regimens in central precocious puberty. J Clin Endocrinol Metab 91:1862-1867
27. Mul D, Bertelloni S, Carel JC, Saggese G, Chaussian JL, Oostdijk W 2002 Effect of gonadotropin-releasing hormone agonist treatment in boys with central precocious puberty: final height results. Horm Res 58:1-7
28. Lazar L, Pertzelan A, Weintob N, Phillip M, Kauli R 2001 Sexual precocity in boys: accelerated versus slowly progressive puberty gonadotropin-suppressive therapy and final height. J Clin Endocrinol Metab 86:4127-4132
29. Rizzo V, De Sanctis V, Corrias A, Fortini M, Galluzzi F, Bertelloni S, Guarnieri MP, Pozzan G, Cisternino M, Pasquino AM 2000 Factors influencing final/near-final height in 12 boys with central precocious puberty treated with gonadotrophin-releasing hormone agonists. Italian Study Group of Physiopathology of Puberty. J Pediatr Endocrinol Metab 13(Suppl 1):781-786